$404 Million is the total value of BVF INC/IL's 32 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FWP | FORWARD PHARMA A/Ssponsored adr | $24,502,000 | -10.5% | 1,441,287 | 0.0% | 6.06% | +29.9% | |
| ONTY | ONCOTHYREON INC | $23,875,000 | -42.8% | 18,799,368 | 0.0% | 5.91% | -16.9% | |
| TBRA | TOBIRA THERAPEUTICS INC | $10,253,000 | -18.6% | 1,253,401 | 0.0% | 2.54% | +18.2% | |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $2,025,000 | -13.0% | 2,500,000 | 0.0% | 0.50% | +26.2% | ||
| CBIO | CATALYST BIOSCIENCES INC | $1,631,000 | -46.3% | 970,948 | 0.0% | 0.40% | -22.0% | |
| GBIM | GLOBEIMMUNE INC | $1,355,000 | -46.6% | 657,653 | 0.0% | 0.34% | -22.6% | |
| MSTX | MAST THERAPEUTICS INC | $1,013,000 | -34.8% | 3,696,961 | 0.0% | 0.25% | -5.3% | |
| BOTA | BIOTA PHARMACEUTIALS INC | $526,000 | -22.8% | 350,776 | 0.0% | 0.13% | +12.1% | |
| NRXGQ | NEPHROGENEX INC | $184,000 | -70.7% | 392,156 | 0.0% | 0.05% | -57.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-18 |
| 4 | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.